Prestige Consumer Healthcare
PBH
#4752
Rank
NZ$3.87 B
Marketcap
NZ$81.70
Share price
2.60%
Change (1 day)
-23.55%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2023 (TTM): NZ-$2.51

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$5.88. In 2022 the company made an earnings per share (EPS) of NZ$7.57 an increase over its 2021 EPS that were of NZ$6.78.

EPS history for Prestige Consumer Healthcare from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$2.51-133.18%
2022NZ$7.5711.7%
2021NZ$6.7813.6%
2020NZ$5.97-651.67%
2019NZ-$1.08-148.78%
2018NZ$2.22-83.29%
2017NZ$13.27437.23%
2016NZ$2.47-34.13%
2015NZ$3.7552.94%
2014NZ$2.45-8.11%
2013NZ$2.6762.64%
2012NZ$1.644.6%
2011NZ$1.5770.59%
2010NZ$0.92-113.97%
2009NZ-$6.58-621.43%
2008NZ$1.267.69%
2007NZ$1.171.56%
2006NZ$1.15-681.82%
2005NZ-$0.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.04 104.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$12.19 107.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.46 61.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.28-78.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.87-17.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$8.78 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$5.77-1.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.19-11.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$53.40-1,008.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.20-62.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel